Primo Biotechnology

Türkiye
Maden, Bayburt Province, Turkey, 10480

Company profile

Primo Biotechnology company profile

Primo Biotechnology harnesses advanced molecular imaging and radiopharmaceutical science to provide precise clinical information via targeted radiopharmaceuticals. Primo Biotechnology aims to form a patient-centric healthcare model and establish doctor-patient relationships founded on trust towards conveying hope and happiness to all patients.

Business identity

Contact email
[email protected]
Phone number
886-2-2537-1160
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2023-01-01, Year

Headquarters

Postal code
10480
Country code
TR
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$14.1M
Last funding
Series A / $7.6M / 2025-07-02
Last equity funding
Series A / $7.6M
Investors
4
Lead investors
2
Founders
2
Articles
20

Founders and investors

Founders

Ya-Yao HuangYe Zhaoyuan

Lead investors

AVA AngelsTaiAn Technologies

Investors

AVA AngelsBank SinoPac (Hong Kong)National Development Fund of Taiwan GovernmentTaiAn Technologies